Experimental stem cell therapy tried in 84-Year-Old stroke patient
NCT ID NCT04907188
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a stem cell treatment (HB-adMSCs) in one 84-year-old man who had a stroke. The cells were taken from his own fat tissue and given through an IV every 28 days for 6 doses. The goal was to see if it was safe and could help him recover. The study is no longer available and was not designed to prove the treatment works for everyone.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
autologous HB-adMSCs (stem cells from the patient's own fat tissue)
What this could lead to
If it works, this could point toward a treatment that helps stroke patients recover by repairing brain damage.
What could go wrong
This is a single-patient expanded access study, not a full clinical trial. Results may not apply to others, and the treatment is still experimental with unknown risks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hope Biosciences Stem Cell Research Foundation
Sugar Land, Texas, 77478, United States